Prep­ping for yet more pricey rare dis­ease drugs, UK launch­es £340M 'In­no­v­a­tive Med­i­cines Fund'

The UK is ex­pand­ing its con­tro­ver­sial Can­cer Drugs Fund in­to rare dis­ease.

On Wednes­day, the coun­try’s Na­tion­al Health Ser­vice an­nounced a new £340 mil­lion ef­fort …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER